Found 607 matching trials
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC PHASE2 This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients PHASE1 This first-in-human open-label, multi center, dose-escalation and expansion...
Show More Location
Liverpool Hospital
Learn More & Join Trial
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer PHASE1 This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C PHASE1 This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma PHASE2 The purpose of this study is to observe and evaluate the efficacy and safet...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma PHASE2 Recent studies suggest that patients with metastatic melanoma whose gut mic...
Show More Learn More & Join Trial
Phase 1 Study of AWT020 in Advanced Cancer PHASE1 The aims of this clinical trial are (1) to assess the safety of AWT020 at d...
Show More Location
ICON Cancer Center South Brisbane
Learn More & Join Trial
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer PHASE1 This phase I/II trial investigates the side effects of genetically engineer...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer PHASE1 This clinical trial will be conducted as a single-center, open-label, Phase...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial